Research study Program year 2020 Source: CMS Open Payments

A Phase Ib Randomized Blinded Placebo Controlled Multiple Ascending Dose Study With Bfkb8488a

Research payments

$2,433,253

251 payments

Through program year 2020, $2,433,253 in research payments was reported against A Phase Ib Randomized Blinded Placebo Controlled Multiple Ascending Dose Study With Bfkb8488a, across 251 payments, paid by Genentech, Inc..

Paid by: Genentech, Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$426,486	65
2019	Research	$2,006,767	186

Breakdown

Who paid Research payments · program years 2019–2020

Genentech, Inc. $2,433,253 251 payments

Who received the money Research payments · program years 2019–2020

Clinical Trials Of Texas INC Organisation paid for research $512,952 43 payments
PharmaSeek, LLC Organisation paid for research $352,420 54 payments
Hassman Research Institute LLC Organisation paid for research $348,261 12 payments
Texas Clinical Research Institute Organisation paid for research $262,340 21 payments
Premier Research Associate INC Organisation paid for research $168,138 14 payments
University Clinic Investigators INC Dba Diabetes Research Center Organisation paid for research $163,986 12 payments
MD Clinical Organisation paid for research $91,964 15 payments
New Orleans Center For Clinical Research Organisation paid for research $91,748 15 payments
Northeast Clinical Research of San Antonio LLC Organisation paid for research $89,884 9 payments
Inland Empire Clinical Trials Organisation paid for research $87,520 6 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.